Prelude Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.5M | 1.0M | 4.27 |
| 2023-09-30 | $3.3M | 1.1M | 3.09 |
| 2023-06-30 | $4.9M | 1.1M | 4.50 |
| 2023-03-31 | $1.6M | 284k | 5.70 |
| 2022-12-31 | $1.8M | 301k | 6.04 |
| 2022-03-31 | $2.2M | 323k | 6.90 |
| 2021-12-31 | $3.8M | 304k | 12.45 |
| 2021-09-30 | $12M | 395k | 31.25 |
| 2021-06-30 | $12M | 401k | 28.63 |
| 2021-03-31 | $18M | 423k | 43.33 |
| 2020-12-31 | $28M | 388k | 71.55 |
| 2020-09-30 | $12M | 400k | 30.13 |